These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17942368)

  • 1. Adenosine as a neuromodulator in neurological diseases.
    Boison D
    Curr Opin Pharmacol; 2008 Feb; 8(1):2-7. PubMed ID: 17942368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine kinase, epilepsy and stroke: mechanisms and therapies.
    Boison D
    Trends Pharmacol Sci; 2006 Dec; 27(12):652-8. PubMed ID: 17056128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neurological diseases: their societal burdens and potential solutions.
    Johnson RT; Price DL
    J Chronic Dis; 1980; 33(3):129-33. PubMed ID: 6444418
    [No Abstract]   [Full Text] [Related]  

  • 4. Modeling Neurotransmission: Computational Tools to Investigate Neurological Disorders.
    Gandolfi D; Boiani GM; Bigiani A; Mapelli J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen radicals and neuropsychiatric illness. Some speculations.
    Lohr JB
    Arch Gen Psychiatry; 1991 Dec; 48(12):1097-106. PubMed ID: 1845228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histamine and diseases of central nervous system].
    Chen Z; Hu WW
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 May; 33(3):185-8. PubMed ID: 15179673
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
    Boison D
    Neurodegener Dis; 2007; 4(1):28-33. PubMed ID: 17429216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine receptors and the central nervous system.
    Sebastião AM; Ribeiro JA
    Handb Exp Pharmacol; 2009; (193):471-534. PubMed ID: 19639292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
    Gomes CV; Kaster MP; Tomé AR; Agostinho PM; Cunha RA
    Biochim Biophys Acta; 2011 May; 1808(5):1380-99. PubMed ID: 21145878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adenosine kinase hypothesis of epileptogenesis.
    Boison D
    Prog Neurobiol; 2008 Mar; 84(3):249-62. PubMed ID: 18249058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in neurodegenerative diseases and cancer.
    de Moura MB; dos Santos LS; Van Houten B
    Environ Mol Mutagen; 2010 Jun; 51(5):391-405. PubMed ID: 20544881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine as a modulator of brain activity.
    Boison D
    Drug News Perspect; 2007 Dec; 20(10):607-11. PubMed ID: 18301794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Pathogenesis of Huntington's chorea, Pick's disease, and paralysis agitans.
    van Wolferen WJ; Bruyn GW; Teepen JL
    Lancet; 1974 Jun; 1(7866):1112. PubMed ID: 4135274
    [No Abstract]   [Full Text] [Related]  

  • 15. Transgenic overexpression of adenosine kinase aggravates cell death in ischemia.
    Pignataro G; Simon RP; Boison D
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):1-5. PubMed ID: 16685255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.
    Sandau US; Colino-Oliveira M; Jones A; Saleumvong B; Coffman SQ; Liu L; Miranda-Lourenço C; Palminha C; Batalha VL; Xu Y; Huo Y; Diógenes MJ; Sebastião AM; Boison D
    J Neurosci; 2016 Nov; 36(48):12117-12128. PubMed ID: 27903722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Adenosine Kinase Inhibitor in Adenosine Augmentation Therapy for Epilepsy: A Potential Novel Drug for Epilepsy.
    Wang X; Li T
    Curr Drug Targets; 2020; 21(3):252-257. PubMed ID: 31633474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticity of purine release during cerebral ischemia: clinical implications?
    Pearson T; Currie AJ; Etherington LA; Gadalla AE; Damian K; Llaudet E; Dale N; Frenguelli BG
    J Cell Mol Med; 2003; 7(4):362-75. PubMed ID: 14754505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hard target: understanding dopaminergic neurotransmission.
    Nestler EJ
    Cell; 1994 Dec; 79(6):923-6. PubMed ID: 8001139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.